Komori
General Meetings of Shareholders4591RIBOMIC Inc.Pharmaceuticals

Supplementary Explanation of the Proposals for the 23rd Annual General Meeting of Shareholders

The Company has submitted to the Annual General Meeting of Shareholders a proposal to amend the Articles of Incorporation to increase the total number of authorized shares in preparation for future funding needs. This is not a decision to issue new stock acquisition rights or shares at this time.

Worth reading
41Recurring
Scored from 3 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (23rd)
2026
Jun 23
Date and time(start time: Not disclosed)8 days from this disclosure to the meeting
Matters for resolution1 item
  1. Partial Amendment to the Articles of Incorporation (Change in the Total Number of Authorized Shares)

Shareholder Proposal

None (only company proposals are listed)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (23rd)
Date and time23 June 2026 (start time: Not disclosed)
Matters for resolutionProposal No. 1: Partial Amendment to the Articles of Incorporation (Change in the Total Number of Authorized Shares)
Shareholder ProposalNone (only company proposals are listed)
Items this document does not state (2)
Director nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to prepare for future funding needs arising from research and development investment, particularly as pipelines under clinical development progress, while ensuring financing options and flexibility in capital policy. The Company also cites the possibility that flexibility could be limited under the current total number of authorized shares, taking into account the number of shares available for issuance upon exercise of the existing 19th and 20th stock acquisition rights.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Explanation of the Proposals for the 23rd Annual General Meeting of Shareholders | RIBOMIC Inc. (4591) timely disclosure | Komori